Nephrocare Health Services Limited

Nephrocare Health Services Limited

Nephrocare Health Services Limited has announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with the reconstitution of the Audit Committee and Stakeholders Relationship Committee. The company also announced the proposed transfer of 51% shareholding in Nephrocare Health Services Saudi Arabia Company to NephroPlus Kidney Services Company as part of an internal restructuring of the Group's overseas holding structure.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about a scheduled investor conference on August 13-14, 2026, where company officials will discuss publicly available information with investors.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange regarding Trading Plan pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about the schedule of its Q1FY27 Earnings Call, to be held on August 12, 2026, at 10:00 A.M IST, where the management will discuss the company's unaudited standalone and consolidated financial results for the quarter ended June 30, 2026.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about the dispatch of Notice of 17th Annual General Meeting of the Company along with the Annual Report of the Company for the financial year 2025-26 and information on remote e-voting.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about General Updates, including the dispatch of a letter providing a web-link of the Annual Report for FY 2025-26 along with AGM Notice. The company has completed the dispatch of the letter to those Members who have not registered their email address with the Company/RTA/Depositories. The Annual Report 2025-26 is also available on the websites of Stock Exchanges.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2026.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about a Copy of Newspaper Publication regarding the Notice of the 17th Annual General Meeting (AGM) and Cut-off date.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about Options to purchase securities - Pursuant to Reg 30 of SEBI Listing Regulations, 2015, the Company has approved allotment of 2,18,297 equity shares of face value of Rs. 2/- each, pursuant to the exercise of stock options under the NephroPlus ESOP Scheme 2011.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has issued a certificate under SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026, regarding the dematerialization and rematerialization of securities.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about giving guarantees/indemnity/becoming a surety for third party, providing collateral/security support in favour of Citibank for the benefit of its overseas subsidiary, Nephrocare Health Services International Pte. Ltd., Singapore, amounting to USD 3,300,000 (equivalent to INR 31.22 Crore).

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about giving guarantees/indemnity/becoming a surety for third party. The Company has executed a Corporate Guarantee Agreement dated May 29, 2026 in favour of Citibank N.A. for securing the credit facilities availed by Nephrocare Health Care Services Philippines Inc., Philippines. The Company has also provided collateral/security support in favour of The Hongkong and Shanghai Banking Corporation Limited for the benefit of Nephrocare Health Services International Pte. Ltd., Singapore.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has informed the Exchange about Agreements. The company has entered into an Asset Transfer Agreement with Curis Dialysis and Kidney Care Center for the acquisition of identified assets relating to a dialysis center located at Orion, Bataan 2102 - Region III (Central Luzon), Philippines, for a total consideration of PhP 151,600,000.

Nephrocare Health Services Limited

Nephrocare Health Services Limited announced that its overseas step-down wholly-owned subsidiary, Nephrocare Health Care Services, Philippines Inc., has entered into an Asset Transfer Agreement. This agreement facilitates the acquisition of identified assets relating to a dialysis center located in Ipil, Zamboanga Sibugay, Philippines. The total consideration for this acquisition is PhP 80,640,000. This move signifies the company's expansion of its healthcare services in the Philippines market.

Nephrocare Health Services Limited

Nephrocare Health Services' board approved the Employee Stock Option Scheme 2026, enabling the grant of up to 2,006,814 options, representing approximately 2% of its paid-up equity share capital, subject to shareholder and regulatory approvals. Concurrently, the company approved providing collateral/security support of up to INR 70 Crore to its overseas step-down wholly-owned subsidiary in Saudi Arabia. This support aims to enable the subsidiary to avail credit facilities, reflecting a revised funding and operating structure for its Saudi operations and facilitating international growth.

Nephrocare Health Services Limited

Nephrocare Health Services Limited has announced the closure of its trading window for designated persons and their immediate relatives. Effective June 22, 2026, this closure adheres to SEBI (Prohibition of Insider Trading) Regulations, 2015. The reason cited is the existence of Unpublished Price Sensitive Information (UPSI), specifically regarding the unaudited financial results for the quarter ending June 30, 2026. The trading window will remain closed until 48 hours after these financial results are publicly declared, preventing insiders from trading on confidential information.

Nephrocare Health Services Limited

Nephrocare Health Services Limited announced a disclosure from its promoter, Edoras Investment Holdings Pte. Ltd., under SEBI Takeover Regulations 31(4). Edoras Investment Holdings confirmed that no new encumbrances were created on its shares in Nephrocare Health Services during the financial year ended March 31, 2026. This annual declaration assures stakeholders that no additional shares were pledged or used as collateral by the promoter during the period. For investors, this indicates stability in the promoter's shareholding, mitigating concerns about potential selling pressure arising from new pledged shares.

Nephrocare Health Services Limited

Investcorp Growth Opportunity Fund has submitted a disclosure under SEBI Takeover Regulations, indicating a potential acquisition or stake increase in Nephrocare Health Services Limited.

Nephrocare Health Services Limited

Investcorp Private Equity Fund II has submitted a disclosure under SEBI Takeover Regulations, 2011, as per Regulation 31(4).